HCN4 antibody (AA 909-1203)

Catalog No. ABIN7877132

This Rabbit Polyclonal antibody specifically detects HCN4 in WB, ELISA and FACS. It exhibits reactivity toward Human, Rat and Mouse.

Quick Overview for HCN4 antibody (AA 909-1203) (ABIN7877132)

Target: HCN4 (Hyperpolarization Activated Cyclic Nucleotide-Gated Potassium Channel 4 (HCN4))

Reactivity: Human, Rat, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This HCN4 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Product Details anti-HCN4 Antibody

Binding Specificity: AA 909-1203

Purpose: HCN4 Antibody

Purification: Antigen affinity purified

Immunogen: Recombinant human HCN4 protein (amino acids H909-L1203) was used as the immunogen for the HCN4 antibody.

Isotype: IgG

Application Details

Application Notes: Optimal dilution of the HCN4 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Storage: 4 °C,-20 °C

Storage Comment: After reconstitution, the HCN4 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Target Details for HCN4

Target: HCN4 (Hyperpolarization Activated Cyclic Nucleotide-Gated Potassium Channel 4 (HCN4))

Alternative Name: HCN4

Background: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 is a protein that in humans is encoded by the HCN4 gene. This gene encodes a member of the hyperpolarization-activated cyclic nucleotide-gated potassium channels. The encoded protein shows slow kinetics of activation and inactivation, and is necessary for the cardiac pacemaking process. This channel may also mediate responses to sour stimuli. Mutations in this gene have been linked to sick sinus syndrome 2, also known as atrial fibrillation with bradyarrhythmia or familial sinus bradycardia. Two pseudogenes have been identified on chromosome 15.

UniProt: Q9Y3Q4